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We thank Taccetti et al. for their comments regarding
our study dClinical outcome of Burkholderia cepacia
complex infection in cystic fibrosisT JCF 2004;3:93–8.
We realize that the conclusion drawn from our study that
patients infected with B. cenocepacia had a greater rate of
decline of FEV1 and BMI than those infected with B.
multivorans is be associated with a significant beta error
due to the small numbers of patients studied especially
those infected with B. multivorans. The data presented by
Taccetti et al., also with small numbers demonstrates
accelerated decline in FEV1 in patients infected with B.
multivorans and B. cenocepacia but they did not find a
difference in lung function decline between the two
groups. Jones et al. [1] also recently reported a similar
study with small numbers of cystic fibrosis patients and
demonstrated a shorter survival in those infected with B.
cenocepacia in comparison to those patients infected with
P. aeruginosa or B. multivorans. Both in our study and
that by Jones et al. [1] the patients infected with B.
cenocepacia were all infected with the same ET12 (IIIA)
strain which has been shown to be more virulent than
other strains Sun et al. [2]. Taccetti et al. did not state
which strain of the B. cenocepacia species was infecting
the patients in the patient population which they studied.1569-1993/$ - see front matter D 2005 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2005.02.001This may explain at least in part the difference demon-
strated between the groups in our study and the study by
Jones et al. [1] and the lack of difference between B.
cenocepacia infected patients and those infected with B.
multivorans in the Italian group. The clinical impact of
organisms in the B. cepacia complex needs further study
to determine between species differences and possible
differences between strains within each species.References
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